Clinical Information
Provent Therapy Has Been Validated in Multiple Peer Reviewed Publications
Provent Therapy is an FDA cleared, prescription-only treatment for obstructive sleep apnea (OSA). It is an effective option for patients who have rejected or are non-compliant with CPAP.
- Provides clinically significant results (reduced AHI (apnea-hypopnea index), ODI (oxygen desaturation index), daytime sleepiness and snoring)
- Works across mild, moderate and severe OSA
- Is well tolerated by patients
Key Publications
- A Novel Nasal Expiratory Positive Airway Pressure (EPAP) Device for the Treatment of Obstructive Sleep Apnea: A Randomized Controlled Trial Berry, RB, Kryger, MH, Massie, CA [Sleep 2011;34 (4):479-485] (19 Center, 3 Month, Randomized Controlled Trial)
- Long term use of a nasal expiratory positive airway pressure (EPAP) device as a treatment for obstructive sleep apnea Kryger MH, Berry RB, Massie CA. [SLEEP Abstract Supplement, 2011 (34):A118] (13 Center, Long Term Efficacy Study)
- Nasal expiratory positive airway pressure (EPAP) for the treatment of obstructive sleep apnea: A review of clinical studies of Provent Therapy Doshi, R, Westbrook P [Respiratory Therapy Vol.6 No.4, 2011:6(4):45-49] (Summary of All Peer Reviewed Studies)
Publications
- A Novel Nasal Expiratory Positive Airway Pressure (EPAP) Device for the Treatment of Obstructive Sleep Apnea: A Randomized Controlled Trial Berry, RB, Kryger, MH, Massie, CA [Sleep 2011;34 (4):479-485]
- Long term use of a nasal expiratory positive airway pressure (EPAP) device as a treatment for obstructive sleep apnea Kryger MH, Berry RB, Massie CA. [Journal of Clinical Sleep Medicine 2011; 7:5:449-453]
- Changes in lung volume and upper airway using MRI during application of nasal expiratory positive airway pressure in patients with sleep disordered breathing. Braga CW, Chen Q, Burschtin O, et al. [Journal of Applied Physiology 2011;111:1400-1409]
- Predictors of response to a nasal expiratory resistor device and its potential mechanisms of action for treatment of obstructive sleep apnea Patel AV, Hwang D, Masdeu MJ et al. [Journal of Clinical Sleep Medicine 2011;7(1):13-22]
- A convenient expiratory positive airway pressure nasal device for the treatment of sleep apnea in patients non-adherent with continuous positive airway pressure Walsh JK, Griffin KS, Forst EH, et al. [Sleep Medicine 2011;12:147-52]
- A multicenter, prospective study of a novel nasal EPAP device in the treatment of obstructive sleep apnea. Efficacy and 30-day adherence Rosenthal L, Massie CA, Dolan DC, et al. [Journal of Clinical Sleep Medicine 2009;5:532-37]
- A pilot evaluation of a nasal expiratory resistance device for the treatment of obstructive sleep apnea Colrain IM, Brooks S, Black J. [Journal of Clinical Sleep Medicine 2008;4(5):426-433]
- Nasal expiratory positive airway pressure (EPAP) for the treatment of obstructive sleep apnea: A review of clinical studies of Provent Therapy Doshi, R, Westbrook P [Respiratory Therapy Vol.6 No.4, 2011:6(4):45-49]
EPAP Posters
- Clinical Efficacy of a Nasal Expiratory Positive Airway Pressure (EPAP) Device for the Treatment of Obstructive Sleep Apnea (OSA) Massie C, Hart RW, as presented at the SLEEP 2011 Annual Conference
- Nasal EPAP as a Major OSA Therapeutic Option in a Clinical Sleep Center Setting Hwang D, Becker K, Chang J et al. as presented at the SLEEP 2011 Annual Conference.
- Retrospective Case Series Analysis of a Nasal Expiratory Positive Airway Pressure (EPAP) Device to Treat Obstructive Sleep Apnea in a Clinical Practice Adams, G, as presented at the SLEEP 2011 Annual Conference.